2001
DOI: 10.1152/ajprenal.2001.280.4.f607
|View full text |Cite
|
Sign up to set email alerts
|

Renal concentrating defect in mice lacking group IV cytosolic phospholipase A2

Abstract: Eicosanoids regulate various cellular functions that are important in physiological and pathophysiological processes. Arachidonic acid is released from membranes by phospholipase A(2) (PLA(2)) activity. Activated macrophages derived from mice lacking the 85-kDa group IV cytosolic PLA(2) (cPLA(2)) have a markedly reduced release of prostaglandin E(2) and leukotrienes B(4) and C(4). Under basal conditions and after furosemide, urinary prostaglandin E(2) excretion is reduced in cPLA(2)-knockout (cPLA(2)(-/-)) mic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
33
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(35 citation statements)
references
References 41 publications
2
33
0
Order By: Relevance
“…The latter mechanism is important, as demonstrated by inhibition of vanadate-induced PGE 2 synthesis and chloride transport by PLA 2 antagonists in rabbit colon 27 and by the abolition of the PGE 2 response to furosemide in knockout mice that are Ϫ/Ϫ for a 85-kDa group IV cytosolic PLA 2 . 28 Therefore, there is no need to invoke an action of furosemide on CYP 450 monooxygenases to account for furosemide-induced stimulation of excretion of 20-HETE, as observed in our SR patients. Increased substrate availability by PLA 2 in response to furosemide could suffice to explain this finding.…”
Section: Discussionmentioning
confidence: 69%
“…The latter mechanism is important, as demonstrated by inhibition of vanadate-induced PGE 2 synthesis and chloride transport by PLA 2 antagonists in rabbit colon 27 and by the abolition of the PGE 2 response to furosemide in knockout mice that are Ϫ/Ϫ for a 85-kDa group IV cytosolic PLA 2 . 28 Therefore, there is no need to invoke an action of furosemide on CYP 450 monooxygenases to account for furosemide-induced stimulation of excretion of 20-HETE, as observed in our SR patients. Increased substrate availability by PLA 2 in response to furosemide could suffice to explain this finding.…”
Section: Discussionmentioning
confidence: 69%
“…Alternatively, the capacity of PGE 2 to influence vasopressin actions in vivo may be less robust than suggested by studies in cell culture or isolated perfused nephron segments (50,52). However, alterations in urinary concentrating capacity did not become apparent in cytosolic phospholipase A2 (cPLA2)-deficient mice until Ͼ320 d of age (24), and our studies were carried out in mice that were Ͻ6 mo of age.…”
Section: Discussionmentioning
confidence: 88%
“…Concentrations of PGEM in urine were determined by using a specific ELISA assay (Cayman Chemicals, Ann Arbor, MI). Previous studies have shown that urinary PGEM is a reliable indicator of urinary PGE 2 excretion in vivo (24). Thromboxane B 2 (TxB 2 ), the stable metabolite of TxA 2 , and 6-keto-PGF 1␣ , the stable metabolite of prostacyclin (PGI 2 ), were measured in fresh urine using specific ELISA (Cayman Chemicals).…”
Section: Measurements Of Urinary Prostanoid Excretionmentioning
confidence: 99%
“…82) Aged cPLA 2 a-deficient mice have abnormality in urine concentrating ability because of reduced aquoporin-1 expression in proximal tubules. 83) Female pregnant mice with the null mutation for cPLA 2 a have difficulties in delivery, and need either cesarean section or administration of progesterone antagonists. 9) This phenotype is explained by the lack of prostaglandin F 2 a production, as a similar failure of delivery was also reported in FP (the receptor for prostaglandin F 2 a)-deficient mice.…”
Section: Physiological and Pathological Rolesmentioning
confidence: 99%